Coronary artery disease and myocardial infarction in patient with carbohydrate disturbances

Nowadays we observe a rapid rise of incidence of diabetes mellitus (DM), especially in developing countries. That is why such a situation can be called an epidemic. Diabetes mellitus is assumed to be an equivalent of coronary artery disease (CAD). Acute myocardial infarction is often diagnosed earlier than DM and is the main cause of death in patients with DM. Percutaneous coronary intervention (PCI) is the most efficient method of reperfusion therapy in the treatment of acute myocardial infarction. It is proved that this method is more efficient than fibrinolytic therapy if it comes to restoration of blood flow in the culprit coronary artery. Percutaneous coronary intervention compared to fibrinolytic therapy is associated with a smaller extent of myocardial injury, better contractility of the left ventricle, and lower rates of death, recurrent myocardial infarctions and strokes within 30-day follow-up. Stent implantation has become a routine procedure. Pharmacological therapy including antiplatelet drugs is a very important issue which improves the results of PCI.